Spersadex comp., collyre en solution

7680305140255 CH-30514 Augentropfen
Spersadex comp., collyre en solution
Spersadex comp., collyre en solution
Spersadex comp., collyre en solution
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
ml
Galenic form
Augentropfen
Galenic group
Augenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
12/10/2023
Patient information leaflet
Français
12/10/2023
Patient information leaflet
Italien
12/10/2023
Summary of Product Characteristics
Allemand
12/10/2023
Summary of Product Characteristics
Français
12/10/2023
Summary of Product Characteristics
Italien
12/10/2023

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 UG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
30.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
200.0 UG Substance HBESI

Reimbursement information

Public price
CHF 14.65
Specialties list
Yes
Generic
No
SL addition date: 15/03/1964

Authorization holder

THEA Pharma S.A.

8200 Schaffhausen

Authorization information

Swissmedic authorization number
30514
Drug name
Spersadex comp., collyre en solution
Galenic form
AUL
ATC Code
S01CA01
Authorization status
Z
Dispensing category
A
First authorization
19/05/1964
Authorization expiration date
31/12/9999
IT Number
11.06.1.
Domain
Human medicine
Field of application
Infizierte Augenentzündungen

Package details

Description (FR)
SPERSADEX comp. gtt opht fl 5 ml
Description (DE)
SPERSADEX comp. Gtt Opht Fl 5 ml
Market launch
20/01/2006
Narcotic (BTM)
No

Other package sizes (1)

None
5 ML
GTIN: None
Not in V1